SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-046992
Filing Date
2018-02-15
Accepted
2018-02-15 13:43:33
Documents
2
Group Members
PONTIFAX (CAYMAN) III, L.P.PONTIFAX (ISRAEL) III, L.P.PONTIFAX MANAGEMENT FUND III L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D d496656dsc13d.htm SC 13D 95963
2 EX-1 d496656dex991.htm EX-99.1 5903
  Complete submission text file 0001193125-18-046992.txt   103445
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89992 | Film No.: 18617096
SIC: 2834 Pharmaceutical Preparations

Mailing Address 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140
Business Address 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140 972-9-9725617
Pontifax Management III G.P. (2011) Ltd. (Filed by) CIK: 0001726335 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13D